Vonoprazan Pharmacology – New Esophagitis Medication Class! Episode 326
Listen now
Description
On this episode, I discuss the new medication vonoprazan and where it will likely be used in practice.
Vonoprazan is from a brand new class of medication called "PCAB". I discuss this medication and its pharmacology in this podcast episode.
Drug interactions and cost are the two major downsides of this medication that will likely limit its use compared to the PPIs.
CYP3A4 inducers like rifampin, carbamazepine, and phenytoin should not be used with vonoprazan. They will reduce the effectiveness of vonoprazan.
More Episodes
In this episode of the Top 200 Drugs Podcast, I cover glyburide, citalopram, olmesratan, carvedilol, and tiotropium.
Glyburide is a sulfonylurea that is well known to cause hypoglycemia and weight gain because it stimulates the pancreas to increase insulin release.
Citalopram is an...
Published 11/14/24
Clindamycin is an antibiotic for infection. It inhibits protein synthesis by binding to the 50s ribosomal subunit and is well known to contribute to C. Diff. risk.
Acetaminophen is a common over-the-counter medication that relieves pain and fever. It does not have much benefit in reducing...
Published 11/07/24
Links
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
